obacunone has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Chen, L; He, J; Hu, S; Huang, F; Jiang, H; Jiang, M; Li, X; Lin, D; Lin, X; Liu, Q; Xu, J; Ye, T; Zeng, Y; Zheng, L | 1 |
| Deng, C; Guo, Y; Hao, D; He, B; Hu, H; Huang, Y; Jian, B; Sun, K; Wang, X; Zhu, J | 1 |
2 other study(ies) available for obacunone and Osteoporosis
| Article | Year |
|---|---|
Obacunone targets macrophage migration inhibitory factor (MIF) to impede osteoclastogenesis and alleviate ovariectomy-induced bone loss.
Topics: Female; Humans; Intramolecular Oxidoreductases; Ligands; Macrophage Migration-Inhibitory Factors; NF-kappa B; Osteogenesis; Osteoporosis; Ovariectomy | 2023 |
Obacunone inhibits RANKL/M-CSF-mediated osteoclastogenesis by suppressing integrin- FAK-Src signaling.
Topics: Animals; Bone Resorption; Cell Differentiation; Female; Focal Adhesion Protein-Tyrosine Kinases; Integrin alpha1; Macrophage Colony-Stimulating Factor; Mice; Osteoclasts; Osteogenesis; Osteoporosis; RANK Ligand; Receptors, Steroid | 2023 |